Literature DB >> 8756367

Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery.

D S Sheth1, A W Yasko, M E Johnson, A G Ayala, J A Murray, M M Romsdahl.   

Abstract

BACKGROUND: Chondrosarcoma (CS) most commonly involves the pelvis. Local and systemic failures often result in poor outcome. Prognostic factors that determine patient outcome remain ill-defined.
METHODS: We retrospectively analyzed 67 patients with CS of the pelvis treated by definitive surgery from January 1970 to December 1992. All patients had localized disease including Grade 1 (19 patients), Grade 2 (18 patients), Grade 3 (17 patients), and dedifferentiated (13 patients) tumors. Thirty-two patients underwent a limb-sparing surgical resection and 35 patients underwent hemipelvectomy. Follow-up was available for all patients. The median duration of follow-up for the survivors was 115 months (range, 24-288 months).
RESULTS: At last follow-up, 52% of the patients were disease free, 8% were alive with disease, 36% died of disease, and 4% died of other causes. Nineteen patients (28%) had developed a local recurrence (LR). The median time to LR was 23 months (range, 1-111 months). Independent variables in a multivariate analysis associated with increased risk of LR included inadequate surgical margin, tumor epicenter in the pubis, and high grade histology. LR did not influence overall patient survival. Twenty-three patients (36%) developed distant metastases at a median time of 9 months (range, 1-111 months) postoperatively. Metastases developed in 0% of the patients with Grade 1, 20% of the patients with Grade 2 60% of the patients with Grade 3 and 75% of patients with dedifferentiated CS. On multivariate analysis, histologic high grade was the only significant predictive variable for distant relapse (P = 0.005).
CONCLUSIONS: The critical issue for a favorable outcome in low grade CS of the pelvis is adequate surgical excision (i.e., negative surgical margin). The high rate of systemic failure in high grade and dedifferentiated CS, despite adequate surgery, emphasizes the need for more effective systemic therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8756367     DOI: 10.1002/(SICI)1097-0142(19960815)78:4<745::AID-CNCR9>3.0.CO;2-D

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

1.  Low-grade chondrosarcoma of bone: experiences from the Vienna Bone and Soft Tissue Tumour Registry.

Authors:  Philipp T Funovics; Joannis Panotopoulos; Manuel Sabeti-Aschraf; Farshid Abdolvahab; Josef M Funovics; Susanna Lang; Rainer I Kotz; Martin Dominkus
Journal:  Int Orthop       Date:  2010-08-28       Impact factor: 3.075

Review 2.  "Advances in the surgical management of bone tumors".

Authors:  Justin E Bird
Journal:  Curr Oncol Rep       Date:  2014-07       Impact factor: 5.075

3.  Survival, local recurrence, and function after pelvic limb salvage at 23 to 38 years of followup.

Authors:  Courtney E Sherman; Mary I O'Connor; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

4.  Sixty percent 10-year survival of patients with chondrosarcoma after local recurrence.

Authors:  Patrick P Lin; Mohammed D Alfawareh; Akihiko Takeuchi; Bryan S Moon; Valerae O Lewis
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

Review 5.  Is it ever safe to discharge a chondrosarcoma of pelvis? Report of a local recurrence after 10 years.

Authors:  Czar Louie L Gaston; Vaiyapuri P Sumathi; Robert J Grimer
Journal:  Musculoskelet Surg       Date:  2012-09-19

Review 6.  [Hemipelvectomy for pelvic sarcomas].

Authors:  W K Guder; J Hardes; M Nottrott; A Streitbürger
Journal:  Orthopade       Date:  2019-09       Impact factor: 1.087

7.  Chondrosarcoma of the pubis imitating bladder tumor radiologically: a case report.

Authors:  Osman Inci; Esat Kaya; Bulent Alagol; Mustafa Kaplan; Latife Doganay
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

8.  Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcoma.

Authors:  Hidetatsu Outani; Kenichiro Hamada; Yoshinori Imura; Kazuya Oshima; Tsukasa Sotobori; Yusuke Demizu; Shigeki Kakunaga; Susumu Joyama; Reiko Imai; Tomoaki Okimoto; Norifumi Naka; Ikuo Kudawara; Takafumi Ueda; Nobuhito Araki; Tadashi Kamada; Hideki Yoshikawa
Journal:  Int J Clin Oncol       Date:  2015-07-07       Impact factor: 3.402

9.  Decancellation sacral osteotomy in iliosacral tumor resection: a technique for precise sacral margins.

Authors:  Yasser R Farid
Journal:  Clin Orthop Relat Res       Date:  2009-08-19       Impact factor: 4.176

10.  Retroperitoneal mesenchymal chondrosarcoma mimicking a large retroperitoneal sacral schwannoma.

Authors:  Giancarlo D'Andrea; Emanuela Caroli; Michela Giuli Capponi; Francesco Scicchitano; Mattia Falchetto Osti; Carlo Bellotti; Luigi Ferrante
Journal:  Neurosurg Rev       Date:  2007-10-03       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.